Epirubicin is intended for Pharmaceuticals, Environment applications. Epirubicin is a stereoisomer of the antitumor anthracycline Doxorubicin. When used either alone or in combination therapies, Epirubicin has been shown to demonstrate high rates of complete or partial remission in various cancers including advanced ovary, lymphomas, breast, pancreas, gastric, hepatocellular carcinoma, head and neck tumors, and colorectal. All information about [13C,2H3]-Epirubicin trifluoroacetate salt is provided in the MSDS. We deliver compounds with high purity levels and a comprehensive Certificate of Analysis. Connect to your member account to consult the documents.